GSK is investing £45 m with the Fleming Initiative to launch six “Grand Challenge” research programmes using cutting-edge AI to tackle antimicrobial resistance against pathogens like MRSA, Gram-negative bacteria, and fungi.
Dr Louise Reardon, Lecturer in Governance and Public Policy at the Institute of Local Government Studies, University of Birmingham, explains how wellbeing is vital to rebuild trust in government.
Mathew Hassell, founder and CEO of Kura, discusses how the school run can be changed to improve the air quality around schools and protect children’s health, following the reduction in pollution amid the UK lockdown.
Sabrina Ruzanski & Emanuele Zannini detail PROTEIN2FOOD, a project that concerns pioneering crops for future generations, most notably, accelerating protein transitions with new plant-based foods.
Here, Mike Brown, Director of Industry Collaboration & Strategic Partnerships at the University of Salford, details the recent developments in electric vehicle innovation and charging infrastructure.
In the face of the current health emergency, Microsoft Azure and Office 365 are inevitably having to scale resources. Andy Powell, Cloud CTO at Jisc, shares advice for dealing with capacity issues.
Innovative technologies have the power to entirely transform the NHS, mitigating the workforce challenges that it faces and transforming the patient experience, whilst improving outcomes, Justin Hall, Vice President and General Manager at iRhythm, discusses here.
Dr. Josef Penninger led an international team from the University of British Columbia to pioneer a trial drug that could stop infection in the early stages of COVID-19.
Jay Sibbitts, Prof Dr Stefan H. Bossmann and Prof Dr Christopher T. Culbertson, from Kansas State University, Department of Chemistry in the U.S., underline microfluidic detection of intracellular nitric oxide levels.
Here, Dr Carlos Ziebert, Karlsruhe Institute of Technology, discusses progress in battery research through safety and ageing studies using calorimeters.
